

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sperm motility (GO:0030317) | 9.72422041 |
| 2 | acrosome reaction (GO:0007340) | 9.06641309 |
| 3 | homocysteine metabolic process (GO:0050667) | 7.80241299 |
| 4 | fusion of sperm to egg plasma membrane (GO:0007342) | 7.48711297 |
| 5 | protein polyglutamylation (GO:0018095) | 7.04482623 |
| 6 | response to lithium ion (GO:0010226) | 7.02690328 |
| 7 | embryonic camera-type eye development (GO:0031076) | 6.68302724 |
| 8 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 6.58840186 |
| 9 | spermatid development (GO:0007286) | 6.43456274 |
| 10 | axonemal dynein complex assembly (GO:0070286) | 6.34485462 |
| 11 | multicellular organism reproduction (GO:0032504) | 6.28375388 |
| 12 | tooth mineralization (GO:0034505) | 6.28363175 |
| 13 | sperm capacitation (GO:0048240) | 6.20239314 |
| 14 | centriole replication (GO:0007099) | 6.09195684 |
| 15 | hair cycle (GO:0042633) | 6.04903181 |
| 16 | molting cycle (GO:0042303) | 6.04903181 |
| 17 | microtubule depolymerization (GO:0007019) | 6.04470005 |
| 18 | regulation of cilium movement (GO:0003352) | 5.94644157 |
| 19 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 5.89241461 |
| 20 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 5.84592279 |
| 21 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 5.84592279 |
| 22 | protein targeting to Golgi (GO:0000042) | 5.79892887 |
| 23 | folic acid metabolic process (GO:0046655) | 5.73676224 |
| 24 | chromosome condensation (GO:0030261) | 5.73395061 |
| 25 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 5.72057833 |
| 26 | mitochondrion transport along microtubule (GO:0047497) | 5.72057833 |
| 27 | plasma membrane fusion (GO:0045026) | 5.66701779 |
| 28 | smooth muscle cell differentiation (GO:0051145) | 5.65794713 |
| 29 | establishment of protein localization to Golgi (GO:0072600) | 5.64353242 |
| 30 | opsonization (GO:0008228) | 5.61417942 |
| 31 | calcium ion-dependent exocytosis (GO:0017156) | 5.61006842 |
| 32 | sperm-egg recognition (GO:0035036) | 5.57642453 |
| 33 | microtubule polymerization or depolymerization (GO:0031109) | 5.54391051 |
| 34 | response to folic acid (GO:0051593) | 5.47895603 |
| 35 | DNA packaging (GO:0006323) | 5.45197744 |
| 36 | cell wall macromolecule catabolic process (GO:0016998) | 5.42531165 |
| 37 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 5.37531567 |
| 38 | bone trabecula formation (GO:0060346) | 5.31381233 |
| 39 | establishment of mitochondrion localization (GO:0051654) | 5.26721352 |
| 40 | reproduction (GO:0000003) | 5.23964297 |
| 41 | protein maturation by protein folding (GO:0022417) | 5.23490081 |
| 42 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 5.21680243 |
| 43 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 5.21241144 |
| 44 | I-kappaB phosphorylation (GO:0007252) | 5.15822844 |
| 45 | centriole assembly (GO:0098534) | 5.13408309 |
| 46 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.10946251 |
| 47 | spermatogenesis (GO:0007283) | 5.08765546 |
| 48 | heart field specification (GO:0003128) | 5.08755053 |
| 49 | secondary heart field specification (GO:0003139) | 5.08755053 |
| 50 | male gamete generation (GO:0048232) | 5.06846738 |
| 51 | response to parathyroid hormone (GO:0071107) | 4.97577436 |
| 52 | positive regulation of hair follicle development (GO:0051798) | 4.96056808 |
| 53 | positive regulation of hair cycle (GO:0042635) | 4.96056808 |
| 54 | cell migration in hindbrain (GO:0021535) | 4.95497934 |
| 55 | cell wall macromolecule metabolic process (GO:0044036) | 4.95135763 |
| 56 | S-adenosylmethionine metabolic process (GO:0046500) | 4.94900462 |
| 57 | cardiac ventricle morphogenesis (GO:0003208) | 4.91347718 |
| 58 | cerebral cortex radially oriented cell migration (GO:0021799) | 4.85653785 |
| 59 | negative regulation of astrocyte differentiation (GO:0048712) | 4.83876451 |
| 60 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 4.82458927 |
| 61 | negative regulation of inclusion body assembly (GO:0090084) | 4.79357439 |
| 62 | gamete generation (GO:0007276) | 4.74423301 |
| 63 | binding of sperm to zona pellucida (GO:0007339) | 4.69234449 |
| 64 | rRNA methylation (GO:0031167) | 4.62812210 |
| 65 | positive regulation of tumor necrosis factor production (GO:0032760) | 4.58902720 |
| 66 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 4.50920321 |
| 67 | cell-cell recognition (GO:0009988) | 4.49380018 |
| 68 | phosphatidylethanolamine metabolic process (GO:0046337) | 4.48839068 |
| 69 | patterning of blood vessels (GO:0001569) | 4.47127015 |
| 70 | epithelial cilium movement (GO:0003351) | 4.46082269 |
| 71 | single fertilization (GO:0007338) | 4.43831532 |
| 72 | RNA destabilization (GO:0050779) | 4.38877740 |
| 73 | microtubule severing (GO:0051013) | 4.36217631 |
| 74 | positive regulation of bone mineralization (GO:0030501) | 4.27209956 |
| 75 | seminiferous tubule development (GO:0072520) | 4.26003053 |
| 76 | cardiac chamber morphogenesis (GO:0003206) | 4.25137500 |
| 77 | regulation of centriole replication (GO:0046599) | 4.25094432 |
| 78 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.23643736 |
| 79 | negative regulation of JAK-STAT cascade (GO:0046426) | 4.20885737 |
| 80 | cilium movement (GO:0003341) | 4.16448166 |
| 81 | motile cilium assembly (GO:0044458) | 4.12359312 |
| 82 | protein localization to Golgi apparatus (GO:0034067) | 4.08316348 |
| 83 | response to pheromone (GO:0019236) | 4.05033904 |
| 84 | regulation of microtubule-based movement (GO:0060632) | 4.03408631 |
| 85 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 4.00077857 |
| 86 | positive regulation of biomineral tissue development (GO:0070169) | 3.97939055 |
| 87 | nodal signaling pathway (GO:0038092) | 3.97548291 |
| 88 | microtubule nucleation (GO:0007020) | 3.97374662 |
| 89 | spermatid nucleus differentiation (GO:0007289) | 3.91881198 |
| 90 | regulation of metalloenzyme activity (GO:0048552) | 3.88291674 |
| 91 | negative regulation of protein localization to cell surface (GO:2000009) | 3.87297609 |
| 92 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 3.87124341 |
| 93 | rRNA modification (GO:0000154) | 3.81331996 |
| 94 | neuronal ion channel clustering (GO:0045161) | 3.81072359 |
| 95 | multicellular organismal reproductive process (GO:0048609) | 3.79715134 |
| 96 | fertilization (GO:0009566) | 3.76721300 |
| 97 | regulation of somitogenesis (GO:0014807) | 3.74596211 |
| 98 | midgut development (GO:0007494) | 3.73019879 |
| 99 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 3.67196604 |
| 100 | regulation of sarcomere organization (GO:0060297) | 3.67045124 |
| 101 | hematopoietic stem cell proliferation (GO:0071425) | 3.65935406 |
| 102 | regulation of collateral sprouting (GO:0048670) | 3.65286409 |
| 103 | germ cell development (GO:0007281) | 3.65245847 |
| 104 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.51983902 |
| 105 | regulation of hair follicle development (GO:0051797) | 3.50021287 |
| 106 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.45969917 |
| 107 | positive regulation of Rab GTPase activity (GO:0032851) | 3.41688081 |
| 108 | regulation of Rab GTPase activity (GO:0032313) | 3.41688081 |
| 109 | cAMP catabolic process (GO:0006198) | 3.41654110 |
| 110 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.40727673 |
| 111 | regulation of meiosis I (GO:0060631) | 3.39430681 |
| 112 | response to water (GO:0009415) | 3.38162082 |
| 113 | 4-hydroxyproline metabolic process (GO:0019471) | 3.36740295 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 3.36237952 |
| 115 | negative regulation of osteoblast proliferation (GO:0033689) | 3.35088772 |
| 116 | cellular process involved in reproduction in multicellular organism (GO:0022412) | 3.31878969 |
| 117 | one-carbon metabolic process (GO:0006730) | 3.30679171 |
| 118 | behavioral response to nicotine (GO:0035095) | 3.28109341 |
| 119 | axoneme assembly (GO:0035082) | 3.27823910 |
| 120 | tetrahydrofolate metabolic process (GO:0046653) | 3.27473645 |
| 121 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.25326385 |
| 122 | specification of organ identity (GO:0010092) | 3.22857167 |
| 123 | sexual reproduction (GO:0019953) | 3.18997289 |
| 124 | single strand break repair (GO:0000012) | 3.17839841 |
| 125 | cyclic nucleotide catabolic process (GO:0009214) | 3.15995846 |
| 126 | hemoglobin metabolic process (GO:0020027) | 3.15098253 |
| 127 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.14394865 |
| 128 | regulation of DNA-templated transcription, initiation (GO:2000142) | 3.12528024 |
| 129 | negative regulation of dendrite development (GO:2000171) | 3.12077323 |
| 130 | endocrine hormone secretion (GO:0060986) | 3.10294641 |
| 131 | activin receptor signaling pathway (GO:0032924) | 3.09597331 |
| 132 | lateral ventricle development (GO:0021670) | 3.09558244 |
| 133 | multicellular organismal movement (GO:0050879) | 3.07022609 |
| 134 | musculoskeletal movement (GO:0050881) | 3.07022609 |
| 135 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 3.06359098 |
| 136 | cellular response to cholesterol (GO:0071397) | 3.04859031 |
| 137 | positive regulation of extracellular matrix organization (GO:1903055) | 3.04451978 |
| 138 | glomerular epithelial cell development (GO:0072310) | 3.04041748 |
| 139 | superoxide anion generation (GO:0042554) | 3.03462026 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.02909740 |
| 141 | negative regulation of glial cell differentiation (GO:0045686) | 3.02247744 |
| 142 | dendrite development (GO:0016358) | 3.02070891 |
| 143 | heart trabecula morphogenesis (GO:0061384) | 3.01988037 |
| 144 | glomerular visceral epithelial cell development (GO:0072015) | 3.01745336 |
| 145 | urinary tract smooth muscle contraction (GO:0014848) | 3.00879282 |
| 146 | regulation of chemokine biosynthetic process (GO:0045073) | 2.98646917 |
| 147 | regulation of inclusion body assembly (GO:0090083) | 2.97313433 |
| 148 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.96795517 |
| 149 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.95758322 |
| 150 | transmission of nerve impulse (GO:0019226) | 2.95291873 |
| 151 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 2.95000980 |
| 152 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 2.95000980 |
| 153 | ketone body metabolic process (GO:1902224) | 2.94315858 |
| 154 | head development (GO:0060322) | 2.93000179 |
| 155 | ventricular system development (GO:0021591) | 2.90560682 |
| 156 | regulation of fever generation (GO:0031620) | 2.86055443 |
| 157 | chromatin silencing (GO:0006342) | 2.85268699 |
| 158 | male sex determination (GO:0030238) | 2.84209735 |
| 159 | regulation of transcription involved in cell fate commitment (GO:0060850) | 2.84054311 |
| 160 | cerebral cortex neuron differentiation (GO:0021895) | 2.81834467 |
| 161 | regulation of platelet aggregation (GO:0090330) | 2.81602730 |
| 162 | positive regulation of heat generation (GO:0031652) | 2.81337198 |
| 163 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 2.78035787 |
| 164 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.77730243 |
| 165 | cellular respiration (GO:0045333) | 2.77059341 |
| 166 | cilium assembly (GO:0042384) | 2.76218691 |
| 167 | alanine transport (GO:0032328) | 2.73945165 |
| 168 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.73318639 |
| 169 | inner ear receptor cell differentiation (GO:0060113) | 2.72832582 |
| 170 | organic cation transport (GO:0015695) | 2.72364050 |
| 171 | dopamine biosynthetic process (GO:0042416) | 2.71847155 |
| 172 | piRNA metabolic process (GO:0034587) | 2.71684990 |
| 173 | response to nerve growth factor (GO:1990089) | 2.71076997 |
| 174 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.71076997 |
| 175 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.70400797 |
| 176 | cilium organization (GO:0044782) | 2.70190157 |
| 177 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.70172645 |
| 178 | regulation of tumor necrosis factor production (GO:0032680) | 2.69929282 |
| 179 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.69141089 |
| 180 | response to peptidoglycan (GO:0032494) | 2.67969463 |
| 181 | trabecula morphogenesis (GO:0061383) | 2.67492314 |
| 182 | nucleus organization (GO:0006997) | 2.67060600 |
| 183 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.62537457 |
| 184 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.61720048 |
| 185 | positive regulation of muscle hypertrophy (GO:0014742) | 2.61720048 |
| 186 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.60643161 |
| 187 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 2.59801999 |
| 188 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.58459402 |
| 189 | response to cholesterol (GO:0070723) | 2.58327911 |
| 190 | regulation of gonadotropin secretion (GO:0032276) | 2.58044976 |
| 191 | regulation of histone H3-K27 methylation (GO:0061085) | 2.57288401 |
| 192 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.57196278 |
| 193 | regulation of hair cycle (GO:0042634) | 2.56311636 |
| 194 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.56308889 |
| 195 | establishment of integrated proviral latency (GO:0075713) | 2.53994803 |
| 196 | response to muramyl dipeptide (GO:0032495) | 2.53915262 |
| 197 | regulation of fibroblast growth factor receptor signaling pathway (GO:0040036) | 2.50397151 |
| 198 | cardiac right ventricle morphogenesis (GO:0003215) | 11.4921183 |
| 199 | cellular response to lithium ion (GO:0071285) | 11.2158552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.15598348 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.57476386 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.49571191 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.91409951 |
| 5 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.80603462 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.74001671 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.48702946 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.48290801 |
| 9 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.47313003 |
| 10 | FUS_26573619_Chip-Seq_HEK293_Human | 2.33493186 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.30375808 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.30250986 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.28585096 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17802060 |
| 15 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.14577341 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12024714 |
| 17 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12024714 |
| 18 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.07758913 |
| 19 | CBP_20019798_ChIP-Seq_JUKART_Human | 2.06570407 |
| 20 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 2.06570407 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.06485163 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.95881266 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.90962465 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.88151513 |
| 25 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.87430116 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.86370073 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84669599 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77816792 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.74914599 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73223943 |
| 31 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71557600 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70566077 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69981236 |
| 34 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67067471 |
| 35 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.64707780 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64409949 |
| 37 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59076065 |
| 38 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.57640990 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56564039 |
| 40 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.55236296 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55180513 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.54789407 |
| 43 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.53774030 |
| 44 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53259238 |
| 45 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.53225007 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51877062 |
| 47 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.50837060 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46758649 |
| 49 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46386691 |
| 50 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.44681960 |
| 51 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43906035 |
| 52 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.40617998 |
| 53 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.39393385 |
| 54 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.39301474 |
| 55 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.38845886 |
| 56 | STAT3_23295773_ChIP-Seq_U87_Human | 1.37496008 |
| 57 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.36226276 |
| 58 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.35895668 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35869328 |
| 60 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.34493918 |
| 61 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31848472 |
| 62 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.31698411 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.30838587 |
| 64 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.30739204 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26119017 |
| 66 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.25703671 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23275732 |
| 68 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.22998794 |
| 69 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.21622385 |
| 70 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20917004 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20476787 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20476787 |
| 73 | ERA_21632823_ChIP-Seq_H3396_Human | 1.19067183 |
| 74 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.19038296 |
| 75 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.18941036 |
| 76 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18433687 |
| 77 | KDM2B_26808549_Chip-Seq_REH_Human | 1.18125383 |
| 78 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17916495 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.17888082 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17792487 |
| 81 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.16862523 |
| 82 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16463251 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.15346006 |
| 84 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.14743303 |
| 85 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14604750 |
| 86 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.12502659 |
| 87 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.12062675 |
| 88 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.11346827 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10492170 |
| 90 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09379516 |
| 91 | TBL1_22424771_ChIP-Seq_293T_Human | 1.08820400 |
| 92 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.08549320 |
| 93 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08367551 |
| 94 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.08249862 |
| 95 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.08185915 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 1.08178655 |
| 97 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.08002610 |
| 98 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.07437477 |
| 99 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.06915951 |
| 100 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06598664 |
| 101 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06488890 |
| 102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05982708 |
| 103 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.05464945 |
| 104 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.05078194 |
| 105 | AR_19668381_ChIP-Seq_PC3_Human | 1.04444296 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04410419 |
| 107 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.04390680 |
| 108 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03533301 |
| 109 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.02967541 |
| 110 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.02919681 |
| 111 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02889501 |
| 112 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.02591185 |
| 113 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02475708 |
| 114 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02051341 |
| 115 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02051341 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01792568 |
| 117 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.01616793 |
| 118 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01360763 |
| 119 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.01049196 |
| 120 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.00030318 |
| 121 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.99213428 |
| 122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99028790 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.98945627 |
| 124 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98887525 |
| 125 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94725975 |
| 126 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94143648 |
| 127 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94143648 |
| 128 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93027427 |
| 129 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92232482 |
| 130 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.91357768 |
| 131 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.90404855 |
| 132 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89450475 |
| 133 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89249610 |
| 134 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88294402 |
| 135 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.88232852 |
| 136 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87845492 |
| 137 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.87759284 |
| 138 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.87759284 |
| 139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.86118148 |
| 140 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.85853326 |
| 141 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.83757943 |
| 142 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.79126724 |
| 143 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.78599970 |
| 144 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77902674 |
| 145 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.75973044 |
| 146 | AR_25329375_ChIP-Seq_VCAP_Human | 0.75780222 |
| 147 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.75716841 |
| 148 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75539915 |
| 149 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75506129 |
| 150 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.74539327 |
| 151 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.73948588 |
| 152 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.73680701 |
| 153 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.73500602 |
| 154 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.73281698 |
| 155 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.72758759 |
| 156 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.72143770 |
| 157 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.71862765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 7.55150613 |
| 2 | MP0002102_abnormal_ear_morphology | 4.44229896 |
| 3 | MP0003879_abnormal_hair_cell | 3.86557143 |
| 4 | MP0001299_abnormal_eye_distance/ | 3.74767591 |
| 5 | MP0005451_abnormal_body_composition | 3.29982424 |
| 6 | MP0003303_peritoneal_inflammation | 3.25958894 |
| 7 | MP0003698_abnormal_male_reproductive | 3.23359363 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.77229138 |
| 9 | MP0005187_abnormal_penis_morphology | 2.72626124 |
| 10 | MP0006138_congestive_heart_failure | 2.71630117 |
| 11 | MP0004858_abnormal_nervous_system | 2.69877598 |
| 12 | MP0001929_abnormal_gametogenesis | 2.62213952 |
| 13 | MP0003890_abnormal_embryonic-extraembry | 2.48972368 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.48912054 |
| 15 | MP0002928_abnormal_bile_duct | 2.47595238 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.45790610 |
| 17 | MP0001485_abnormal_pinna_reflex | 2.30319405 |
| 18 | MP0001529_abnormal_vocalization | 2.27586227 |
| 19 | MP0001486_abnormal_startle_reflex | 2.17006068 |
| 20 | MP0000579_abnormal_nail_morphology | 2.16420121 |
| 21 | MP0008004_abnormal_stomach_pH | 2.14670184 |
| 22 | MP0005670_abnormal_white_adipose | 2.14555924 |
| 23 | MP0001727_abnormal_embryo_implantation | 2.10129792 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.05054871 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.04643037 |
| 26 | MP0001984_abnormal_olfaction | 2.00142002 |
| 27 | MP0003718_maternal_effect | 1.97923702 |
| 28 | MP0005257_abnormal_intraocular_pressure | 1.97854188 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.97444531 |
| 30 | MP0005248_abnormal_Harderian_gland | 1.90553619 |
| 31 | MP0003880_abnormal_central_pattern | 1.83038044 |
| 32 | MP0002161_abnormal_fertility/fecundity | 1.82326362 |
| 33 | MP0001188_hyperpigmentation | 1.81598287 |
| 34 | MP0003045_fibrosis | 1.80898883 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.77348517 |
| 36 | MP0005166_decreased_susceptibility_to | 1.73540669 |
| 37 | MP0001348_abnormal_lacrimal_gland | 1.70307295 |
| 38 | MP0001340_abnormal_eyelid_morphology | 1.69950406 |
| 39 | MP0001905_abnormal_dopamine_level | 1.69855900 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.69391504 |
| 41 | MP0003123_paternal_imprinting | 1.66747338 |
| 42 | MP0006082_CNS_inflammation | 1.62618885 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.60694901 |
| 44 | MP0000026_abnormal_inner_ear | 1.58154541 |
| 45 | MP0000631_abnormal_neuroendocrine_gland | 1.54685482 |
| 46 | MP0003941_abnormal_skin_development | 1.54455413 |
| 47 | MP0002572_abnormal_emotion/affect_behav | 1.52791059 |
| 48 | MP0002098_abnormal_vibrissa_morphology | 1.48562567 |
| 49 | MP0004859_abnormal_synaptic_plasticity | 1.48000240 |
| 50 | MP0004484_altered_response_of | 1.43913526 |
| 51 | MP0001963_abnormal_hearing_physiology | 1.43393199 |
| 52 | MP0005310_abnormal_salivary_gland | 1.42760565 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.42566382 |
| 54 | MP0003448_altered_tumor_morphology | 1.42528019 |
| 55 | MP0003075_altered_response_to | 1.39548899 |
| 56 | MP0004510_myositis | 1.34813323 |
| 57 | MP0004270_analgesia | 1.34803968 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.33955896 |
| 59 | MP0002272_abnormal_nervous_system | 1.33815507 |
| 60 | MP0002210_abnormal_sex_determination | 1.33000165 |
| 61 | MP0003690_abnormal_glial_cell | 1.31168233 |
| 62 | MP0005332_abnormal_amino_acid | 1.31057116 |
| 63 | MP0003121_genomic_imprinting | 1.31011382 |
| 64 | MP0003436_decreased_susceptibility_to | 1.28305918 |
| 65 | MP0004133_heterotaxia | 1.27545312 |
| 66 | MP0006276_abnormal_autonomic_nervous | 1.27034459 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 1.23669408 |
| 68 | MP0005330_cardiomyopathy | 1.22657667 |
| 69 | MP0003878_abnormal_ear_physiology | 1.22051553 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 1.22051553 |
| 71 | MP0003938_abnormal_ear_development | 1.21309124 |
| 72 | MP0002971_abnormal_brown_adipose | 1.21167431 |
| 73 | MP0004885_abnormal_endolymph | 1.18605147 |
| 74 | MP0002282_abnormal_trachea_morphology | 1.18144304 |
| 75 | MP0008961_abnormal_basal_metabolism | 1.16968635 |
| 76 | MP0002064_seizures | 1.16726891 |
| 77 | MP0000920_abnormal_myelination | 1.15747108 |
| 78 | MP0002557_abnormal_social/conspecific_i | 1.15209253 |
| 79 | MP0000534_abnormal_ureter_morphology | 1.15059274 |
| 80 | MP0005365_abnormal_bile_salt | 1.14289369 |
| 81 | MP0002419_abnormal_innate_immunity | 1.12790336 |
| 82 | MP0003646_muscle_fatigue | 1.12323528 |
| 83 | MP0000778_abnormal_nervous_system | 1.11795031 |
| 84 | MP0009745_abnormal_behavioral_response | 1.11765943 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 1.09513237 |
| 86 | MP0005367_renal/urinary_system_phenotyp | 1.08524107 |
| 87 | MP0000516_abnormal_urinary_system | 1.08524107 |
| 88 | MP0009046_muscle_twitch | 1.07973578 |
| 89 | MP0003136_yellow_coat_color | 1.07679183 |
| 90 | MP0003787_abnormal_imprinting | 1.05779871 |
| 91 | MP0000653_abnormal_sex_gland | 1.05760950 |
| 92 | MP0004811_abnormal_neuron_physiology | 1.05156298 |
| 93 | MP0000537_abnormal_urethra_morphology | 1.05095472 |
| 94 | MP0002736_abnormal_nociception_after | 1.04902913 |
| 95 | MP0000733_abnormal_muscle_development | 1.04207761 |
| 96 | MP0005464_abnormal_platelet_physiology | 1.03629581 |
| 97 | MP0005025_abnormal_response_to | 1.02828463 |
| 98 | MP0001970_abnormal_pain_threshold | 1.02609358 |
| 99 | MP0000955_abnormal_spinal_cord | 1.02316970 |
| 100 | MP0003635_abnormal_synaptic_transmissio | 1.02102557 |
| 101 | MP0002234_abnormal_pharynx_morphology | 1.01826078 |
| 102 | MP0001145_abnormal_male_reproductive | 1.00803270 |
| 103 | MP0004947_skin_inflammation | 0.98017370 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.97787938 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.95610179 |
| 106 | MP0005395_other_phenotype | 0.95564869 |
| 107 | MP0008569_lethality_at_weaning | 0.95564384 |
| 108 | MP0005171_absent_coat_pigmentation | 0.95021214 |
| 109 | MP0002006_tumorigenesis | 0.94902212 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.94856501 |
| 111 | MP0008770_decreased_survivor_rate | 0.94601255 |
| 112 | MP0003632_abnormal_nervous_system | 0.94529164 |
| 113 | MP0000613_abnormal_salivary_gland | 0.94230936 |
| 114 | MP0004742_abnormal_vestibular_system | 0.94088230 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.93919978 |
| 116 | MP0002166_altered_tumor_susceptibility | 0.93355851 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.90947045 |
| 118 | MP0000604_amyloidosis | 0.90667542 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.90562936 |
| 120 | MP0003186_abnormal_redox_activity | 0.90460526 |
| 121 | MP0005165_increased_susceptibility_to | 0.90054722 |
| 122 | MP0002896_abnormal_bone_mineralization | 0.89685553 |
| 123 | MP0005448_abnormal_energy_balance | 0.86436096 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.85153225 |
| 125 | MP0002132_abnormal_respiratory_system | 0.84574986 |
| 126 | MP0001293_anophthalmia | 0.84489369 |
| 127 | MP0002229_neurodegeneration | 0.84481939 |
| 128 | MP0003631_nervous_system_phenotype | 0.84006753 |
| 129 | MP0003329_amyloid_beta_deposits | 0.83862847 |
| 130 | MP0002063_abnormal_learning/memory/cond | 0.83299766 |
| 131 | MP0000343_altered_response_to | 0.82829755 |
| 132 | MP0002882_abnormal_neuron_morphology | 0.82731010 |
| 133 | MP0003828_pulmonary_edema | 0.82685139 |
| 134 | MP0005076_abnormal_cell_differentiation | 0.81954319 |
| 135 | MP0000762_abnormal_tongue_morphology | 0.81747336 |
| 136 | MP0009379_abnormal_foot_pigmentation | 0.81603052 |
| 137 | MP0005535_abnormal_body_temperature | 0.81090221 |
| 138 | MP0000367_abnormal_coat/_hair | 0.79721287 |
| 139 | MP0005646_abnormal_pituitary_gland | 0.79597267 |
| 140 | MP0005360_urolithiasis | 0.78187349 |
| 141 | MP0008874_decreased_physiological_sensi | 0.77156061 |
| 142 | MP0003724_increased_susceptibility_to | 0.76821890 |
| 143 | MP0009764_decreased_sensitivity_to | 0.76774571 |
| 144 | MP0001968_abnormal_touch/_nociception | 0.75067576 |
| 145 | MP0005000_abnormal_immune_tolerance | 0.73832701 |
| 146 | MP0005379_endocrine/exocrine_gland_phen | 0.73184393 |
| 147 | MP0001440_abnormal_grooming_behavior | 0.73178490 |
| 148 | MP0003861_abnormal_nervous_system | 0.72124763 |
| 149 | MP0003011_delayed_dark_adaptation | 0.72045038 |
| 150 | MP0003868_abnormal_feces_composition | 0.71928757 |
| 151 | MP0008789_abnormal_olfactory_epithelium | 0.71085541 |
| 152 | MP0002822_catalepsy | 0.68589033 |
| 153 | MP0000383_abnormal_hair_follicle | 0.68282148 |
| 154 | MP0002152_abnormal_brain_morphology | 0.68218818 |
| 155 | MP0000569_abnormal_digit_pigmentation | 0.67304941 |
| 156 | MP0003959_abnormal_lean_body | 0.65060884 |
| 157 | MP0002733_abnormal_thermal_nociception | 0.64442779 |
| 158 | MP0005387_immune_system_phenotype | 0.64186231 |
| 159 | MP0001790_abnormal_immune_system | 0.64186231 |
| 160 | MP0002249_abnormal_larynx_morphology | 0.63663917 |
| 161 | MP0004085_abnormal_heartbeat | 0.63118333 |
| 162 | MP0010368_abnormal_lymphatic_system | 0.63102388 |
| 163 | MP0005394_taste/olfaction_phenotype | 0.62483574 |
| 164 | MP0005499_abnormal_olfactory_system | 0.62483574 |
| 165 | MP0002066_abnormal_motor_capabilities/c | 0.61797970 |
| 166 | MP0002752_abnormal_somatic_nervous | 0.60487656 |
| 167 | MP0002108_abnormal_muscle_morphology | 0.60368377 |
| 168 | MP0008872_abnormal_physiological_respon | 0.60242891 |
| 169 | MP0000538_abnormal_urinary_bladder | 0.59702001 |
| 170 | MP0005386_behavior/neurological_phenoty | 0.58683219 |
| 171 | MP0004924_abnormal_behavior | 0.58683219 |
| 172 | MP0001270_distended_abdomen | 0.58456981 |
| 173 | MP0005083_abnormal_biliary_tract | 0.58437236 |
| 174 | MP0005636_abnormal_mineral_homeostasis | 0.56304586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic hepatic failure (HP:0100626) | 8.56700362 |
| 2 | Split foot (HP:0001839) | 7.77609124 |
| 3 | Homocystinuria (HP:0002156) | 7.49847745 |
| 4 | Abnormality of homocysteine metabolism (HP:0010919) | 7.49847745 |
| 5 | Oligodactyly (hands) (HP:0001180) | 7.38583802 |
| 6 | Turricephaly (HP:0000262) | 7.29970784 |
| 7 | Oligodactyly (HP:0012165) | 7.08724932 |
| 8 | Mixed hearing impairment (HP:0000410) | 5.96484219 |
| 9 | Natal tooth (HP:0000695) | 5.77099687 |
| 10 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.06839340 |
| 11 | Absent/shortened dynein arms (HP:0200106) | 5.06839340 |
| 12 | Severe visual impairment (HP:0001141) | 5.00742909 |
| 13 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.86582734 |
| 14 | Stenosis of the external auditory canal (HP:0000402) | 4.55489001 |
| 15 | Neonatal death (HP:0003811) | 4.53967349 |
| 16 | Nephronophthisis (HP:0000090) | 4.53752312 |
| 17 | Choanal stenosis (HP:0000452) | 4.53651859 |
| 18 | Protruding tongue (HP:0010808) | 4.43582704 |
| 19 | Tubulointerstitial nephritis (HP:0001970) | 4.40414520 |
| 20 | Absent hand (HP:0004050) | 4.36905230 |
| 21 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.34846962 |
| 22 | Abnormal ciliary motility (HP:0012262) | 4.28274610 |
| 23 | Long toe (HP:0010511) | 4.17349610 |
| 24 | Cheilitis (HP:0100825) | 4.17096059 |
| 25 | Cone-rod dystrophy (HP:0000548) | 4.04403973 |
| 26 | Focal motor seizures (HP:0011153) | 3.91853382 |
| 27 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.74071208 |
| 28 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.74071208 |
| 29 | Abnormality of the renal medulla (HP:0100957) | 3.73139489 |
| 30 | Onycholysis (HP:0001806) | 3.68049636 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 3.65513264 |
| 32 | Pancreatic cysts (HP:0001737) | 3.55236903 |
| 33 | True hermaphroditism (HP:0010459) | 3.54983017 |
| 34 | Amelogenesis imperfecta (HP:0000705) | 3.54110953 |
| 35 | Facial shape deformation (HP:0011334) | 3.53340153 |
| 36 | Potter facies (HP:0002009) | 3.53340153 |
| 37 | Pancreatic fibrosis (HP:0100732) | 3.45066553 |
| 38 | Occipital encephalocele (HP:0002085) | 3.42566095 |
| 39 | Intellectual disability, moderate (HP:0002342) | 3.42355486 |
| 40 | Progressive inability to walk (HP:0002505) | 3.37620206 |
| 41 | Unilateral renal agenesis (HP:0000122) | 3.33305098 |
| 42 | Hyperkalemia (HP:0002153) | 3.33143973 |
| 43 | Molar tooth sign on MRI (HP:0002419) | 3.31328437 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 3.31328437 |
| 45 | Large earlobe (HP:0009748) | 3.29983003 |
| 46 | Recurrent cutaneous fungal infections (HP:0011370) | 3.24075315 |
| 47 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.24075315 |
| 48 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.19849623 |
| 49 | Papilledema (HP:0001085) | 3.18572408 |
| 50 | Advanced eruption of teeth (HP:0006288) | 3.15197509 |
| 51 | Round ear (HP:0100830) | 3.10225714 |
| 52 | Cystic liver disease (HP:0006706) | 3.09371824 |
| 53 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.07437402 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.02380084 |
| 55 | Progressive cerebellar ataxia (HP:0002073) | 3.01798735 |
| 56 | Abnormality of dental color (HP:0011073) | 3.01114579 |
| 57 | Hepatocellular carcinoma (HP:0001402) | 3.00526003 |
| 58 | Postural instability (HP:0002172) | 2.99897416 |
| 59 | Male infertility (HP:0003251) | 2.98313008 |
| 60 | Portal hypertension (HP:0001409) | 2.95071893 |
| 61 | Tubulointerstitial abnormality (HP:0001969) | 2.94324886 |
| 62 | Nasal polyposis (HP:0100582) | 2.89892235 |
| 63 | Impulsivity (HP:0100710) | 2.89387671 |
| 64 | Attenuation of retinal blood vessels (HP:0007843) | 2.86236442 |
| 65 | Rhinitis (HP:0012384) | 2.85143275 |
| 66 | Toxemia of pregnancy (HP:0100603) | 2.80573138 |
| 67 | Renovascular hypertension (HP:0100817) | 2.79307457 |
| 68 | Abnormal hemoglobin (HP:0011902) | 2.77986904 |
| 69 | Infertility (HP:0000789) | 2.76206310 |
| 70 | Abnormal biliary tract physiology (HP:0012439) | 2.75761129 |
| 71 | Bile duct proliferation (HP:0001408) | 2.75761129 |
| 72 | Progressive sensorineural hearing impairment (HP:0000408) | 2.73004950 |
| 73 | Hypoplastic pelvis (HP:0008839) | 2.71330959 |
| 74 | Relative macrocephaly (HP:0004482) | 2.69795332 |
| 75 | Epiphyseal dysplasia (HP:0002656) | 2.69401398 |
| 76 | Abnormality of the hepatic vasculature (HP:0006707) | 2.66777067 |
| 77 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.66120534 |
| 78 | Hypoplastic ischia (HP:0003175) | 2.64179393 |
| 79 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 2.63565352 |
| 80 | Aqueductal stenosis (HP:0002410) | 2.63487017 |
| 81 | Limited elbow extension (HP:0001377) | 2.63399219 |
| 82 | Eczematoid dermatitis (HP:0000976) | 2.54938763 |
| 83 | Anencephaly (HP:0002323) | 2.52495696 |
| 84 | Stage 5 chronic kidney disease (HP:0003774) | 2.48967617 |
| 85 | Abnormality of macular pigmentation (HP:0008002) | 2.48447793 |
| 86 | Chronic bronchitis (HP:0004469) | 2.46409718 |
| 87 | Conical tooth (HP:0000698) | 2.44948566 |
| 88 | Obsessive-compulsive behavior (HP:0000722) | 2.39742318 |
| 89 | Focal segmental glomerulosclerosis (HP:0000097) | 2.38405897 |
| 90 | Split hand (HP:0001171) | 2.38399078 |
| 91 | Resting tremor (HP:0002322) | 2.32865606 |
| 92 | Abnormal drinking behavior (HP:0030082) | 2.32421958 |
| 93 | Polydipsia (HP:0001959) | 2.32421958 |
| 94 | Abnormality of the ischium (HP:0003174) | 2.29536379 |
| 95 | Hypoplasia of the thymus (HP:0000778) | 2.27908144 |
| 96 | Joint hemorrhage (HP:0005261) | 2.27824203 |
| 97 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.25821410 |
| 98 | Abnormality of the nasal mucosa (HP:0000433) | 2.25249629 |
| 99 | Truncal obesity (HP:0001956) | 2.24408319 |
| 100 | Glossoptosis (HP:0000162) | 2.22639196 |
| 101 | Stroke (HP:0001297) | 2.21346358 |
| 102 | Sclerocornea (HP:0000647) | 2.21312114 |
| 103 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.17027807 |
| 104 | Stomatitis (HP:0010280) | 2.16463394 |
| 105 | Bell-shaped thorax (HP:0001591) | 2.15122756 |
| 106 | Recurrent skin infections (HP:0001581) | 2.15046714 |
| 107 | Deep venous thrombosis (HP:0002625) | 2.14395671 |
| 108 | Subacute progressive viral hepatitis (HP:0006572) | 2.13986565 |
| 109 | Hemiplegia (HP:0002301) | 2.13274352 |
| 110 | Hypoalphalipoproteinemia (HP:0003233) | 2.11548742 |
| 111 | Absent toe (HP:0010760) | 2.11159763 |
| 112 | Hypophosphatemia (HP:0002148) | 2.10598887 |
| 113 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.10573992 |
| 114 | Amyloidosis (HP:0011034) | 2.09569360 |
| 115 | Subcapsular cataract (HP:0000523) | 2.08597417 |
| 116 | Menstrual irregularities (HP:0000858) | 2.07980211 |
| 117 | Bronchiectasis (HP:0002110) | 2.07814552 |
| 118 | Aplasia of the phalanges of the hand (HP:0009802) | 2.04404139 |
| 119 | Aplasia involving bones of the extremities (HP:0009825) | 2.04404139 |
| 120 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.04404139 |
| 121 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.03749445 |
| 122 | Abnormal urine output (HP:0012590) | 2.03578645 |
| 123 | Optic nerve hypoplasia (HP:0000609) | 2.03195839 |
| 124 | Plagiocephaly (HP:0001357) | 2.02067081 |
| 125 | Parakeratosis (HP:0001036) | 2.01072327 |
| 126 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.01014446 |
| 127 | Fragile skin (HP:0001030) | 2.00012875 |
| 128 | Elevated alkaline phosphatase (HP:0003155) | 1.99955769 |
| 129 | Partial duplication of thumb phalanx (HP:0009944) | 1.99680114 |
| 130 | Recurrent fungal infections (HP:0002841) | 1.99385939 |
| 131 | Abnormality of the pubic bones (HP:0003172) | 1.98912124 |
| 132 | Abnormality of potassium homeostasis (HP:0011042) | 1.97588248 |
| 133 | Breast hypoplasia (HP:0003187) | 1.96324898 |
| 134 | Striae distensae (HP:0001065) | 1.95785978 |
| 135 | Congenital sensorineural hearing impairment (HP:0008527) | 1.93217083 |
| 136 | Recurrent corneal erosions (HP:0000495) | 1.92080752 |
| 137 | Hypoplasia of dental enamel (HP:0006297) | 1.91103800 |
| 138 | Hyperuricemia (HP:0002149) | 1.90916363 |
| 139 | Increased purine levels (HP:0004368) | 1.90916363 |
| 140 | Esophageal atresia (HP:0002032) | 1.90742480 |
| 141 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.90401314 |
| 142 | Arterial tortuosity (HP:0005116) | 1.90235383 |
| 143 | Congenital hepatic fibrosis (HP:0002612) | 1.90232789 |
| 144 | Polyuria (HP:0000103) | 1.86793184 |
| 145 | Urticaria (HP:0001025) | 1.85820534 |
| 146 | Tubulointerstitial fibrosis (HP:0005576) | 1.85785563 |
| 147 | Short 5th finger (HP:0009237) | 1.84463106 |
| 148 | Male pseudohermaphroditism (HP:0000037) | 1.83101593 |
| 149 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.82658226 |
| 150 | Tubular atrophy (HP:0000092) | 1.82164003 |
| 151 | Glomerulosclerosis (HP:0000096) | 1.80787906 |
| 152 | Small hand (HP:0200055) | 1.77154000 |
| 153 | Xerostomia (HP:0000217) | 1.76225261 |
| 154 | Preauricular skin tag (HP:0000384) | 1.75746090 |
| 155 | Oculomotor apraxia (HP:0000657) | 1.75324354 |
| 156 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.75032869 |
| 157 | Focal seizures (HP:0007359) | 1.74948710 |
| 158 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74832886 |
| 159 | Partial duplication of the phalanx of hand (HP:0009999) | 1.74619080 |
| 160 | Inability to walk (HP:0002540) | 1.74580577 |
| 161 | Medial flaring of the eyebrow (HP:0010747) | 1.73817579 |
| 162 | Genital tract atresia (HP:0001827) | 1.73759277 |
| 163 | Abnormal albumin level (HP:0012116) | 1.73616738 |
| 164 | Hypoalbuminemia (HP:0003073) | 1.73616738 |
| 165 | Coxa vara (HP:0002812) | 1.73615968 |
| 166 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73103685 |
| 167 | Abnormality of the renal cortex (HP:0011035) | 1.72288989 |
| 168 | Protrusio acetabuli (HP:0003179) | 1.72018005 |
| 169 | Prostate neoplasm (HP:0100787) | 1.72003827 |
| 170 | Protruding ear (HP:0000411) | 1.71790754 |
| 171 | Abnormality of macrophages (HP:0004311) | 1.71686772 |
| 172 | Vaginal atresia (HP:0000148) | 1.71505800 |
| 173 | Abnormality of renal excretion (HP:0011036) | 1.70343133 |
| 174 | Gait imbalance (HP:0002141) | 1.69755894 |
| 175 | Hemoptysis (HP:0002105) | 1.69056970 |
| 176 | Prolonged partial thromboplastin time (HP:0003645) | 1.68199048 |
| 177 | Short femoral neck (HP:0100864) | 1.68129548 |
| 178 | Ventricular fibrillation (HP:0001663) | 1.67301083 |
| 179 | Cerebral palsy (HP:0100021) | 1.66635564 |
| 180 | Volvulus (HP:0002580) | 1.66528046 |
| 181 | Loss of speech (HP:0002371) | 1.66168594 |
| 182 | Paresthesia (HP:0003401) | 1.64388755 |
| 183 | Vascular tortuosity (HP:0004948) | 1.64127824 |
| 184 | Trismus (HP:0000211) | 1.63409237 |
| 185 | Hypoplastic female external genitalia (HP:0012815) | 1.61709675 |
| 186 | Athetosis (HP:0002305) | 1.61640504 |
| 187 | Vacuolated lymphocytes (HP:0001922) | 1.58739211 |
| 188 | Sparse lateral eyebrow (HP:0005338) | 1.56788164 |
| 189 | Hydronephrosis (HP:0000126) | 1.53949699 |
| 190 | Pruritus (HP:0000989) | 1.52321841 |
| 191 | Midface retrusion (HP:0011800) | 1.52213168 |
| 192 | Myokymia (HP:0002411) | 1.51193706 |
| 193 | Brachycephaly (HP:0000248) | 1.50561313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 8.41893505 |
| 2 | PNCK | 7.26568172 |
| 3 | DAPK2 | 6.09869060 |
| 4 | PLK4 | 5.85859927 |
| 5 | MAPK7 | 5.70251336 |
| 6 | PRPF4B | 5.14508515 |
| 7 | RPS6KC1 | 3.57188212 |
| 8 | RPS6KL1 | 3.57188212 |
| 9 | CAMK1G | 3.55268056 |
| 10 | MAPK15 | 3.26368747 |
| 11 | BRD4 | 3.18966780 |
| 12 | RPS6KA6 | 3.18776967 |
| 13 | TAOK2 | 2.73602300 |
| 14 | MST1R | 2.66857075 |
| 15 | DAPK1 | 2.32305840 |
| 16 | CLK1 | 2.22704021 |
| 17 | TESK1 | 2.19091961 |
| 18 | NUAK1 | 1.92089089 |
| 19 | MAP4K2 | 1.81866492 |
| 20 | DAPK3 | 1.69044087 |
| 21 | MAP3K2 | 1.53430453 |
| 22 | STK38 | 1.51056213 |
| 23 | EPHB2 | 1.46858272 |
| 24 | PTK2B | 1.40291207 |
| 25 | NTRK3 | 1.38661786 |
| 26 | ICK | 1.34807381 |
| 27 | MET | 1.16594108 |
| 28 | YES1 | 1.16089352 |
| 29 | CAMK1D | 1.14075301 |
| 30 | ERN1 | 1.13371403 |
| 31 | NEK6 | 1.09639599 |
| 32 | FRK | 0.98188361 |
| 33 | SIK2 | 0.96786244 |
| 34 | BMX | 0.96755887 |
| 35 | STK38L | 0.96745073 |
| 36 | MAP3K14 | 0.96289152 |
| 37 | TAOK1 | 0.94597137 |
| 38 | EPHA4 | 0.91161050 |
| 39 | PDK1 | 0.88977288 |
| 40 | MAP3K4 | 0.88591459 |
| 41 | PRKD3 | 0.88099241 |
| 42 | MUSK | 0.87124782 |
| 43 | MINK1 | 0.86864886 |
| 44 | MAPKAPK5 | 0.84549323 |
| 45 | ERBB4 | 0.83455068 |
| 46 | CAMK1 | 0.82520109 |
| 47 | RIPK4 | 0.79510017 |
| 48 | TBK1 | 0.78807048 |
| 49 | PRKG2 | 0.78632442 |
| 50 | TXK | 0.77318010 |
| 51 | WNK4 | 0.75105206 |
| 52 | PDPK1 | 0.74901431 |
| 53 | PIK3CG | 0.74669020 |
| 54 | PRKCG | 0.72074439 |
| 55 | MAP3K11 | 0.71765236 |
| 56 | KSR2 | 0.67942980 |
| 57 | MTOR | 0.65012825 |
| 58 | CASK | 0.65003437 |
| 59 | PBK | 0.64116192 |
| 60 | CDK11A | 0.63809041 |
| 61 | DDR2 | 0.62930042 |
| 62 | PAK2 | 0.61516631 |
| 63 | IKBKE | 0.59827848 |
| 64 | PAK6 | 0.59506165 |
| 65 | AKT3 | 0.56036890 |
| 66 | CSK | 0.55009798 |
| 67 | CDK15 | 0.54405895 |
| 68 | CDK14 | 0.53268052 |
| 69 | MAPK9 | 0.51816993 |
| 70 | CDK18 | 0.49961908 |
| 71 | DYRK1B | 0.49673782 |
| 72 | CDK3 | 0.47392084 |
| 73 | PRKCZ | 0.46755114 |
| 74 | STK11 | 0.44644019 |
| 75 | MST4 | 0.44405974 |
| 76 | ARAF | 0.43579291 |
| 77 | CAMKK2 | 0.43118007 |
| 78 | LMTK2 | 0.42898358 |
| 79 | ABL2 | 0.41955660 |
| 80 | CSNK1A1L | 0.41903718 |
| 81 | CDK7 | 0.41269954 |
| 82 | TIE1 | 0.40848193 |
| 83 | TNIK | 0.40365102 |
| 84 | NTRK1 | 0.39258393 |
| 85 | GSK3B | 0.39109449 |
| 86 | ADRBK2 | 0.39029229 |
| 87 | RIPK1 | 0.38411093 |
| 88 | RPS6KA1 | 0.38347685 |
| 89 | CAMK4 | 0.38193496 |
| 90 | MAP2K2 | 0.37691558 |
| 91 | STK39 | 0.37319894 |
| 92 | MAPK10 | 0.36330360 |
| 93 | CDK1 | 0.35038587 |
| 94 | WNK3 | 0.34171263 |
| 95 | BMPR1B | 0.33869846 |
| 96 | UHMK1 | 0.33304667 |
| 97 | NTRK2 | 0.31276218 |
| 98 | DYRK1A | 0.30004481 |
| 99 | PIM2 | 0.29792379 |
| 100 | PKN1 | 0.28997341 |
| 101 | CDK2 | 0.28366143 |
| 102 | INSR | 0.27797748 |
| 103 | FGFR2 | 0.27148300 |
| 104 | MARK2 | 0.27133969 |
| 105 | MAP3K13 | 0.27058578 |
| 106 | PLK2 | 0.26851136 |
| 107 | CAMK2B | 0.26703760 |
| 108 | ROCK1 | 0.26159341 |
| 109 | TRIB3 | 0.25296609 |
| 110 | CDK6 | 0.24294417 |
| 111 | DYRK2 | 0.23348770 |
| 112 | RPS6KA3 | 0.22225904 |
| 113 | INSRR | 0.22200250 |
| 114 | SGK1 | 0.22059549 |
| 115 | PRKAA2 | 0.21990086 |
| 116 | GRK7 | 0.20446236 |
| 117 | MAPK8 | 0.18873240 |
| 118 | CAMK2D | 0.18777597 |
| 119 | GRK1 | 0.18459373 |
| 120 | EIF2AK2 | 0.18419398 |
| 121 | LYN | 0.17572543 |
| 122 | WEE1 | 0.17258739 |
| 123 | MAPK12 | 0.17101687 |
| 124 | PRKCE | 0.16933434 |
| 125 | MAPK3 | 0.16892310 |
| 126 | PRKACA | 0.16697644 |
| 127 | HCK | 0.16637139 |
| 128 | MAPKAPK3 | 0.16464185 |
| 129 | PRKCB | 0.15920900 |
| 130 | LCK | 0.15604462 |
| 131 | MAPK1 | 0.15486286 |
| 132 | CCNB1 | 0.15347216 |
| 133 | BRAF | 0.14506092 |
| 134 | EGFR | 0.14445817 |
| 135 | MAP3K7 | 0.14287340 |
| 136 | OXSR1 | 0.13587424 |
| 137 | TTN | 0.13531901 |
| 138 | PRKACB | 0.13450694 |
| 139 | TAOK3 | 0.13388466 |
| 140 | IGF1R | 0.13293644 |
| 141 | MARK1 | 0.12788008 |
| 142 | FYN | 0.12718030 |
| 143 | MAPK14 | 0.12605978 |
| 144 | CAMKK1 | 0.12604045 |
| 145 | PRKACG | 0.12512990 |
| 146 | CDK5 | 0.11998407 |
| 147 | CAMK2G | 0.11805605 |
| 148 | MAPK13 | 0.11652204 |
| 149 | LRRK2 | 0.10817291 |
| 150 | CAMK2A | 0.08658383 |
| 151 | PRKCH | 0.08126326 |
| 152 | MAP2K1 | 0.07872248 |
| 153 | ERBB2 | 0.07664734 |
| 154 | CSNK1A1 | 0.06823641 |
| 155 | PRKG1 | 0.06639722 |
| 156 | ABL1 | 0.06621195 |
| 157 | RPS6KA5 | 0.06202461 |
| 158 | MAP3K9 | 0.06114072 |
| 159 | GRK5 | 0.05980992 |
| 160 | FES | 0.05880389 |
| 161 | TYRO3 | 0.05839110 |
| 162 | WNK1 | 0.05593477 |
| 163 | PHKG2 | 0.05497347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 7.03695998 |
| 2 | One carbon pool by folate_Homo sapiens_hsa00670 | 4.49699116 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.13486099 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 3.35454672 |
| 5 | Axon guidance_Homo sapiens_hsa04360 | 3.17588912 |
| 6 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.84511269 |
| 7 | Taste transduction_Homo sapiens_hsa04742 | 2.79699996 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 2.16046407 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.07126496 |
| 10 | Hepatitis B_Homo sapiens_hsa05161 | 2.06842705 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 1.90784803 |
| 12 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.90248257 |
| 13 | Platelet activation_Homo sapiens_hsa04611 | 1.88096526 |
| 14 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.84214454 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.83648567 |
| 16 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.76971600 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69745806 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.65553098 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.64837221 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.63770785 |
| 21 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.59933284 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.51518722 |
| 23 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.47707147 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.45967836 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.45822306 |
| 26 | HTLV-I infection_Homo sapiens_hsa05166 | 1.42930774 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42800449 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40939253 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.33321333 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.33320569 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30276259 |
| 32 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.30019934 |
| 33 | Melanogenesis_Homo sapiens_hsa04916 | 1.28220606 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.26098624 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23334992 |
| 36 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.21104167 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.20864631 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.19158489 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.18808778 |
| 40 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.15954225 |
| 41 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.12808653 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11441283 |
| 43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09424012 |
| 44 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.07861244 |
| 45 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.07508361 |
| 46 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.04265462 |
| 47 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.02085533 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.02079438 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 1.02010393 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01597369 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01278719 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 0.99016074 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96300030 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94721274 |
| 55 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.94279117 |
| 56 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.93494230 |
| 57 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.91812522 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91667087 |
| 59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.91466033 |
| 60 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91139073 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.90908604 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89691483 |
| 63 | Cocaine addiction_Homo sapiens_hsa05030 | 0.89139872 |
| 64 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89050756 |
| 65 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88297569 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 0.87967742 |
| 67 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.87158316 |
| 68 | RNA transport_Homo sapiens_hsa03013 | 0.86377259 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86026143 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83130005 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.81809829 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.81565723 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.81240290 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80837321 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.80810175 |
| 76 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.78744396 |
| 77 | GABAergic synapse_Homo sapiens_hsa04727 | 0.78126848 |
| 78 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77703672 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76925950 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76193415 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75730268 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75384391 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74939323 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.74919231 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74304551 |
| 86 | Nicotine addiction_Homo sapiens_hsa05033 | 0.73590259 |
| 87 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73249464 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72715134 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72335997 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.72171883 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.70206548 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.69433052 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68956463 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68719953 |
| 95 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.67690324 |
| 96 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65924736 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65629021 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63422066 |
| 99 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62890956 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.61550038 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.61293339 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.59954140 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58955849 |
| 104 | Melanoma_Homo sapiens_hsa05218 | 0.58320857 |
| 105 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56382704 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.56005376 |
| 107 | Allograft rejection_Homo sapiens_hsa05330 | 0.55783475 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55300141 |
| 109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55060938 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.54718708 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54576530 |
| 112 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54219671 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53984780 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53894866 |
| 115 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53095024 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52704823 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52247347 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51371514 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51137984 |
| 120 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49345613 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48582763 |
| 122 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.48015971 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47776802 |
| 124 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46951579 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46708177 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46310606 |
| 127 | Lysine degradation_Homo sapiens_hsa00310 | 0.45979259 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45358712 |
| 129 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.45326937 |
| 130 | Alcoholism_Homo sapiens_hsa05034 | 0.44253984 |
| 131 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.43644613 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43629181 |
| 133 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43146162 |
| 134 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42706233 |
| 135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42608450 |
| 136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42222651 |
| 137 | Renin secretion_Homo sapiens_hsa04924 | 0.42152752 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42046075 |
| 139 | Carbon metabolism_Homo sapiens_hsa01200 | 0.41368601 |
| 140 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41198834 |
| 141 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.40936424 |
| 142 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40857792 |
| 143 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40771342 |
| 144 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40747512 |
| 145 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39691895 |
| 146 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39412987 |
| 147 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39217203 |
| 148 | Mineral absorption_Homo sapiens_hsa04978 | 0.39066500 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.38838664 |
| 150 | Influenza A_Homo sapiens_hsa05164 | 0.38748363 |
| 151 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.38408030 |
| 152 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38405130 |
| 153 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36039754 |
| 154 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35369926 |
| 155 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32511930 |
| 156 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32003540 |
| 157 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31498328 |
| 158 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30036040 |
| 159 | Tight junction_Homo sapiens_hsa04530 | 0.27670363 |
| 160 | Endocytosis_Homo sapiens_hsa04144 | 0.27367978 |
| 161 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26249722 |
| 162 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23794938 |
| 163 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23766249 |
| 164 | Purine metabolism_Homo sapiens_hsa00230 | 0.21373550 |

